Cargando…
Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome
OBJECTIVE: To explore the relationship between serum omentin, C1q/tumor necrosis factor-related protein-9 (CTRP9), and visceral fat-specific serine protease inhibitor (vaspin) levels in different phenotypes in patients with polycystic ovary syndrome (PCOS). METHODS: One hundred PCOS patients treated...
Autores principales: | Wang, Yuhong, Liu, Ning, Lu, Jing, Yang, Liping, Wang, Changyan, Chen, Jing, Chang, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402309/ https://www.ncbi.nlm.nih.gov/pubmed/36034953 http://dx.doi.org/10.1155/2022/1862404 |
Ejemplares similares
-
Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome
por: Guvenc, Yesim, et al.
Publicado: (2016) -
Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017) -
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
por: Cantarini, L, et al.
Publicado: (2011) -
The role of the novel adipokines vaspin and omentin in chronic inflammatory diseases
por: Radzik-Zając, Joanna, et al.
Publicado: (2022) -
Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)